Abstract
The kinetics of alkaline hydrolysis of N-(5-nitro-2-thiazolyl)-2-thiophenylcarboxamide (tenonitrozole or atrican) has been studied by photometric and polarographic techniques, and the thermodynamic parameters in the intermediate state of this process were determined. A mechanism explaining the nitric oxide (NO) production during the hydrolytic decomposition of tenonitrozole is proposed. It is suggested that the antiprotozoal and antimicrobial activity of this drug under anaerobic conditions is related to the formation of nitro radical anions and NO. Under aerobic and microaerophilic conditions, the hydrolysis of tenonitrozole may lead to the formation of a peroxynitrite anion, which is a strong cytotoxic agent.
Similar content being viewed by others
REFERENCES
V. G. Granik and N. B. Grigor'ev, Izv. Ross. Akad. Nauk, Ser. Khim., No. 8, 1268–1313 (2002).
A. K. Mirzabalaeva and M. A. Kakheli, Bull. Dermatol. Venerol., No. 4, 35–37 (1997).
M. Dymicky, C. N. Huhtenen, and A. E. Wesserman, Antimicrob. Agents Chemother., 12(3), 353–365 (1977).
C. Viode, N. Bettache, N. Cenas, et al., Biochem. Pharmacol., 57(5), 549–557 (1999).
J. Samuelson, Antimicrob. Agents Chemother., 43(7), 1533–1541 (1999).
G. V. Chechekin, V. I. Levina, A. P. Arzamastsev, and V. G. Granik, Khim. Geterotsikl. Soedin., No. 7, 902–906 (1999).
N. B. Grigor'ev, V. I. Levina, O. V. Azizov, et al., Vopr. Biol. Med. Pharm. Khim., No. 4, 10–14 (2002).
V. I. Levina, O. V. Azizov, N. V. Pyatakova, et al., Vopr. Biol. Med. Pharm. Khim., No. 4, 6–10 (2002).
J. V. Metzger, Thiazole and Its Derivatives, in: the Chemistry of Heterocyclic Compounds, A. Weissberger and E. C. Taylor (eds.), Wiley, New York (1979), Vol. 34, Part 1.
Author information
Authors and Affiliations
Additional information
__________
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 39, No. 6, pp. 15 – 18, June, 2005.
Rights and permissions
About this article
Cite this article
Trukhacheva, L.A., Levina, V.I., Arzamastsev, A.P. et al. Alkaline Hydrolysis Kinetics and No-Donor Activity of Tenonitrozole. Pharm Chem J 39, 296–299 (2005). https://doi.org/10.1007/s11094-005-0137-5
Received:
Issue Date:
DOI: https://doi.org/10.1007/s11094-005-0137-5